Phase 4 N=307 Concomitant, Sequential, and Standard Triple Therapy for H. Pylori Infection
Helicobacter Pylori Infection
Primary: Number of Participants With Complete Eradication of Helicobacter Pylori — 102; 100; 101 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=950 A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation
Atrial Fibrillation
Primary: The Rate of Complete Effectiveness of Initial GIS Management Strategy — 55.9; 67.2 percentage of participants — p=0.2554
Phase 4 N=216 AbsorbaTack Evaluation of Postoperative Pain Following Laparoscopic Hernia Repair
Hernia, Inguinal · Hernia, Ventral
Primary: Postoperative Pain — .8; 2.0; 2.2; 3.3 units on a scale
Phase 4 N=51 Vildagliptin vs Sitagliptin add-on to Insulin - Impact on Glycemic Profile and Correlation of Hypoglycemic Episodes and Heart Function
Diabetes Mellitus Type 2
Primary: Hypoglycemic Profile of Vildagliptin Compared to Sitagliptin Over 4 Days After 8 Weeks of Treatment in Period 1 & 2 — 11.2; 5.3 mmol/L/4d
Phase 4 N=46 Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression
Major Depressive Disorder Without Psychotic Features
Primary: Change in MADRS Total Score — -14.29; -11.61 units on a scale
Phase 4 N=151 Efficacy and Safety of Etanercept in Active RA Despite Methotrexate Therapy in Japan
Rheumatoid Arthritis
Primary: EULAR Good Response — 33.3; 52.1 percentage of responders
Phase 4 N=22 Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study
Acne Rosacea
Primary: Investigator Global Assessment (IGA) at Baseline — 3; 3.1 units on a scale
Phase 4 N=120 Parastomal Reinforcement With Strattice
Parastomal Hernia
Primary: Occurrence of Parastomal Hernia in Subjects Undergoing Permanent Abdominal Wall Ostomy Creation With and Without Strattice Fascial Inlay. — 6; 7 participants
Phase 4 N=241 Evaluation of Reader Training Processes
Alzheimer's Disease
Primary: Agreement Between Expert Panel and Clinical Practice Reads — 0.745 Weighted Kappa statistic
Phase 4 N=5 Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant Patients
Hepatitis B
Primary: Differences in Blood Glucose Levels as Measured by GNS-POC, GS-POC and Venous Blood Prior to and After HBIG Injection — -3.2; 6.0; 56.6; -2.6 mg/dL — p=0.59
Phase 4 N=70 Telephone Based Management of Hyperlipidemia
Hyperlipidemia
Primary: LDL Level Change From Baseline — -63.4; -54.6 mg/dl — p=0.391
Phase 4 N=93 Response of Cardiac Resynchronization Therapy Optimization With Ventricle to Ventricle Timing in Heart Failure Patients
Heart Failure
Primary: CRT Responder Rate — 16; 20; 17; 6 participants
Phase 4 N=245 An Interventional Study to Assess the Efficacy and Safety of Buprenorphine in Korean Patients With Spinal Disorders
Spinal Disorder
Primary: Change of Pain Intensity* at Week 8 of Treatment With the Study Drug From Baseline — -1.65 units on a scale — p=<0.05
Phase 4 N=11 The Effect of Glucomannan Soluble Fiber on Glucose Homeostasis in Patients With Roux En Y (RNY) Gastric Bypass Surgery
Hypoglycemia
Primary: Difference Score: Percent of Time Spent in Hypoglycemic State — 1.2 Difference score, trt-control (percent) — p=0.99
Phase 4 N=49 Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS)
Hypertension
Primary: Change in Renal Plasma Flow in Response to Infused Angiotensin II — -54.1; -10.8 ml/minute